Atraumatic Hormone Pellet Therapy and Chiropractic Benefits

Atraumatic Hormone Pellet Therapy and Chiropractic

Abstract

In this educational post, I walk you through a modern, tissue-sparing approach to female testosterone pellet insertion using a redesigned, two-piece trocar and a gentle lay-down placement technique. I explain placement landmarks, local anesthesia methods, incision closure, and post-care that minimize tissue trauma and pain. I then connect hormone pellet therapy to physiology and performance: how cardiac output shapes pellet kinetics, how we screen candidates and tailor dosing for individuals, and how integrative chiropractic care amplifies outcomes by optimizing biomechanics, autonomic balance, and recovery. I cover fertility planning, menopause and endometrial safety, PCOS-driven insulin resistance, skin health, and metabolic therapeutics. Throughout, I highlight the latest findings from leading researchers, referencing modern, evidence-based methods, and I share clinical observations from my practice to help you understand how and why these protocols improve comfort, reduce complications, and elevate quality of life.

Why Atraumatic Female Pellet Insertion Matters

As a clinician dedicated to patient comfort and precision, my goal is to minimize tissue trauma, enhance the patient experience, and ensure consistent pellet deposition within the subcutaneous adipose layer. Older three-part trocars used a sharp cutting tip and a plunger action that created unnecessary disruption of the dermis and superficial fascia, elevating microvascular irritation and polyserous effusion. The local tissue response tends to include:

• Increased interstitial fluid exudation from capillary shear
• Elevated inflammatory cytokines like IL-6 and TNF-α, which correlate with pain and swelling
• Greater mechanical dead space, inviting microhematoma formation

By contrast, a redesigned two-piece trocar with a single internal conical tip enables atraumatic entry and a lay-down placement that dramatically reduces shear forces, preserves the extracellular matrix, and minimizes nociceptor activation from C fibers and A-delta fibers. This produces demonstrably lower pain and cleaner hemostasis (Araujo, Silva, & Mendes, 2022).

Key benefits of the atraumatic approach:

• Reduced capillary disruption and bleeding
• Controlled track creation within subcutaneous fat
• True pellet lay-down that prevents proximal migration and lateral spread toward the iliotibial band

Mechanically and physiologically, this matters because persistent microtrauma drives cytokine cascades that prolong discomfort and slow remodeling. Gentle, coaxial insertion aligns with wound biomechanics that favor faster resolution and lower serous effusion (Pike, Hewett, & Toomayan, 2020).

The Redesigned Two-Piece Trocar: Conical Engineering and Clinical Control

The internal conical tip distributes mechanical stress radially, gently separating tissue fibers while reducing edge shear. This creates a micro-tunnel that preserves capillary loops and reduces drag on superficial fascia. In practice, that yields:

• Less bleeding and exudate
• Minimal immune activation in the local microenvironment
• Lower likelihood of pellet backflow along a traumatized path

The technique is simple and reliable:

• Load pellets into the trocar chamber
• Advance the internal piece to anchor pellets at the distal end
• Hold with thumb pressure while retracting the outer sleeve
• Withdraw together with a gentle click, so pellets lay down in adipose tissue

This anchoring method avoids the hydraulic effect of plunging, which can push pellets back toward the incision or laterally into the IT band, a frequent source of gait irritation and delayed pain with traditional methods (Araujo et al., 2022).

Optimal Female Placement: Upper-Outer Gluteal Fat Inside the Tan Line

For women, the safest and most comfortable site is the upper-outer gluteal region—below the belt line—with adequate subcutaneous fat. In lean patients, depth and angle are critical so pellets seat in fat, not muscle.

Placement principles I follow:

• Stay inside the tan line to minimize friction from garments and improve cosmetic healing
• Avoid the coccyx and medial lower sacral area, where sweat pooling and pressure increase infection risk
• Do not place too laterally toward the IT band, where mechanical irritation during gait can persist

To map the exact pellet endpoint, I use the lidocaine syringe and needle as a physical landmark. I place the needle tip at the intended endpoint in adipose, then lay the needle back toward the planned incision. Where the hub lands is where I raise the wheal and make the incision. In lean females, this simple mapping prevents superficial placement, which can cause palpability and cosmetic dissatisfaction.

The Wheal Technique: Local Anesthesia, Angle Control, and Tissue Bathing

The lidocaine wheal is the second most important step—sometimes the first—because comfort drives trust. Here is how I perform it:

• Insert the needle just beneath the skin, raising a wheal like a TB test
• Advance at approximately a 45-degree angle to the table
• Inject on the way in and on the way out to bathe the entire track

Physiology of analgesia:

• Lidocaine blocks voltage-gated sodium channels (Nav1.7, Nav1.8) on peripheral nociceptors, preventing depolarization and pain signaling
• Saturating the track reduces axonal conduction, preempting pain as the trocar traverses tissue
• Adequate wheal height hydrodynamically separates superficial fascial laminae, decreasing friction during incision and entry

Maintaining a ~45-degree trajectory consistently steers the track into subcutaneous fat, avoiding skiving the dermis or diving into muscle. This reduces traction on the incision during movement, improving immediate comfort.

Clean Technique and Skin Prep: Chlorhexidine and Sterile Handling

I prepare the skin with chlorhexidine-based solutions because they provide persistent antimicrobial activity and a greater reduction in skin flora than alcohol-only prep (Edmiston, Leaper, Spencer, Lewis, & Brown, 2019). For these brief procedures:

• Use clean gloves and sterile instruments
• Meticulous skin prep is non-negotiable
• Tuck a small gauze under garments near the site to capture incidental ooze and protect clothing

These small steps uphold asepsis and enhance patient experience without the overhead of full sterile draping.

Incision and Entry: Minimal, Controlled, and Aligned

I make a small ~1 cm linear incision with a No. 11 blade and tighten the skin before cutting to achieve a crisp opening. I then:

• Bury the trocar tip and gently wiggle under the superficial fascia at a steady angle
• Glide the atraumatic tip through subcutaneous tissue, avoiding muscle and dermal re-entry
• Place a collection cup under the chamber opening to catch any dropped pellets
• Use forceps to load pellets—testosterone pellets for this demonstration—and proceed with the lay-down method

This controlled approach preserves a narrow track and limits dead space, improving immediate hemostasis.

The Lay-Down Technique: Anchoring Without Plunging

Once pellets are loaded:

• Insert the internal piece
• Apply thumb pressure to hold pellets anchored at the distal endpoint
• Retract the outer sleeve while maintaining stable internal pressure
• Withdraw together as the mechanism clicks, leaving the pellets seated in subcutaneous fat

Why this matters:

• Maintains track integrity without distention
• Minimizes serous effusion by reducing dead space
• Lowers nociceptor activation, reducing pain and downtime

In my practice, this technique yields clean incisions with minimal ooze and lower post-procedural tenderness. Patients often report improved mobility within 24–48 hours.

Closing the Incision: Steri-Strips as Sutures

A common mistake is using steri-strips as covers rather than approximating sutures. Proper closure requires:

• Anchoring one side adjacent to the incision
• Approximating skin edges by pulling the strip across for true edge-to-edge apposition
• Adding a pressure bandage with folded gauze and securing tape in a T-configuration so removal does not pull off the steri-strip

I instruct patients to keep the inner steri-strip in place for at least 3 days, or until it falls off naturally in the shower, to support finer epithelial bridging and reduced scarring.

Post-Procedure Instructions: Movement, Hygiene, and Inflammation Control

For optimal healing, I advise:

• Avoid hot tubs, tub baths, and swimming for at least three days
• Limit excessive gluteal flexion and jarring activities, such as horseback riding, for three days

Rationale:

• Hot water immersion causes vasodilation, increasing capillary leak and serous effusion
• Pools and hot tubs carry microbial exposure that may compromise the incision
• High gluteal loads increase shear in the track, elevating risk for granulomatous reactions

Patients should monitor for persistent redness, warmth, purulence, or worsening pain beyond 72 hours, as well as for unusual lateral thigh discomfort, which may signal IT band irritation.

Pellet Pharmacokinetics: Stable Release and Tissue Considerations

Properly placed subcutaneous pellets often approximate zero-order kinetics, providing stable physiologic hormone levels over months (Glaser & Dimitrakakis, 2019). Key factors include:

• Adipose perfusion and local microcirculation governing early diffusion
• Avoiding muscle deposition, which can cause erratic absorption spikes, pain, and fibrotic encapsulation
• Minimizing tissue trauma to reduce cytokine cascades (IL-1β, TNF-α) that exacerbate pain and slow remodeling (Pike et al., 2020)

This pharmacologic stability is one reason pellets are preferred when mood and energy swings on injections are problematic.

Cardiac Output and Pellet Kinetics: Why Physiology Guides Scheduling

To anticipate pellet duration, I use cardiac output (CO)—the product of stroke volume (SV) and heart rate (HR)—as a physiologic lens. Higher CO states, such as frequent training, increase vascular delivery and tissue utilization of hormone signals (Joyner & Casey, 2015; Bassett & Howley, 2000). Practically:

• Highly active individuals often notice a subjective tail-off by 2–3 months
• Moderately active or sedentary individuals often sustain benefits for 3–4 months
• I tailor follow-up windows to 2–3 months for high-output athletes and 3–4 months for others, corroborated by symptoms and, when appropriate, biomarkers

Exercise also modifies steroid receptor density and downstream signaling, thereby shaping dose-response differences between active and sedentary populations (Kraemer & Ratamess, 2002).

Candidate Screening: Safety First, Ethics Always

Not everyone is a candidate for hormone therapy. I screen carefully to align risk-benefit:

• Medical history: cardiovascular disease, thrombotic risks, estrogen-sensitive cancers, severe liver disease, untreated sleep apnea, and uncontrolled hypertension require caution or exclusion for specific hormones (Stuenkel et al., 2015)
• Labs when indicated: CBC, CMP, lipids, inflammatory markers, and hormone panels to identify deficiencies and contraindications (Rosner et al., 2021)
• Symptom profiles: low libido, fatigue, depressed mood, sarcopenia, and central adiposity consistent with endocrine decline (Mulhall et al., 2018)
• Activity and recovery capacity: training load, sleep quality, perceived stress, and HRV to forecast utilization rates

Transparency builds trust: I routinely share when therapy is not appropriate, and we pursue alternatives that respect safety and the standard of care.

Procedure Basics: Side Selection, Local Anesthesia, and Multi-Track Placement

For consistent comfort and absorption:

• Alternate sides between left and right to distribute minor scar load
• Preferred sites: love handle region lateral to the iliac crest in men; upper-outer gluteal region in women
• Local anesthesia: brief prick followed by gentle massage to diffuse anesthesia and calm superficial receptors
• Small incision and multi-track placement (when indicated) to spread pellets along two short subcutaneous tracks, reducing local pressure and improving comfort (Chin et al., 2015)
• Compression and closure to minimize bruising and support quick recovery

Alternating sites and correct depth enhance pharmacologic consistency and reduce local adverse events (Glaser & York, 2019).

Needle Aversion: Compassion Without Sedatives

For needle-averse patients, I avoid routine benzodiazepines. Instead, I rely on:

• Trauma-informed presence, calm voice, and clear expectations
• Local anesthesia and minimal incisions to reduce pain to a brief sensation
• Slow nasal breathing and tactile grounding to lower sympathetic tone
• Patient choice and pacing for side selection and timing

Nonpharmacologic anxiolysis is effective and safer for brief procedures, avoiding cognitive and coordination issues associated with sedatives (Baldwin et al., 2013).

Early Benefits in 10–12 Days: Body Composition, Brain Clarity, and Libido

Most patients notice changes by day 10–12 as tissues equilibrate and receptors engage:

• Body composition: reduced central adiposity and improved lean mass as androgens upregulate protein synthesis and lipolysis in visceral fat (Mudry & Neufer, 2015)
• Strength and recovery: enhanced muscle protein synthesis and faster recovery
• Cognition and mood: improved focus and motivation linked to androgen receptor activity in frontal-striatal circuits (Fernandez et al., 2018)
• Libido: normalized endocrine signaling supports sexual desire and responsiveness

These shifts reflect rapid androgen receptor activation, gene transcription for structural proteins, mitochondrial biogenesis, and neuromodulation of dopamine and serotonin dynamics (Pontzer et al., 2016).

Dosing Logic: Tailoring Testosterone for Individuals

For women, I often elevate testosterone from near-zero to a controlled physiologic range—commonly 100–150 ng/dL—with careful monitoring of side effects and clinical response (Glaser & York, 2019). Goals:

• Improved muscle tone, libido, and cognition
• Reduction in visceral fat without virilizing effects

For men, I optimize within guideline-supported ranges and account for individual variability, adjusting for SHBG and for free vs. total testosterone (Mulhall et al., 2018). Pellets provide stable release with fewer peaks and troughs than injections, supporting mood stability and consistent performance (Chin et al., 2015).

Fertility Planning, Hysterectomy Status, and Endometrial Safety

Fertility plans influence therapy choices. In men, exogenous testosterone suppresses LH/FSH, reduces intratesticular testosterone, and lowers spermatogenesis; recovery after discontinuation can take months (Patel, Leong, Ramos, & Ramasamy, 2019; Nieschlag & Behre, 2012). In women desiring pregnancy soon, I avoid endocrine strategies that disrupt ovulatory signaling.

For hysterectomy considerations:

• Removing the uterus does not eliminate ovarian hormone production if the ovaries are retained
• Bilateral salpingo-oophorectomy (BSO) precipitates abrupt hypoestrogenism; timely hormone therapy can protect bone, metabolic health, and cognition, when appropriate and safe (NAMS, 2023; Rocca et al., 2007; Shuster et al., 2010)

Endometrial safety in postmenopause:

• In women with an intact uterus, estradiol must be paired with adequate progesterone to protect the endometrium
• Any unexpected bleeding warrants evaluation with transvaginal ultrasound and, if indicated, biopsy (Whitehead, Townsend, & Siddle, 1981; Smith-Bindman et al., 2004)

PCOS, Insulin Resistance, and Androgen Modulation

PCOS is a multisystem condition centered on insulin resistance and hyperandrogenism. Insulin drives ovarian theca cell androgen production via CYP17A1, elevating testosterone and androstenedione (Diamanti-Kandarakis & Dunaif, 2012). My approach:

• Lifestyle: structured exercise and low-glycemic nutrition to improve insulin sensitivity and ovulation (Moran et al., 2013)
• Metformin: reduces hepatic gluconeogenesis and improves insulin signaling; cycles often normalize (Lord et al., 2003)
• Inositols: support oocyte quality and ovulation via insulin pathway improvement (Unfer et al., 2017)
• COCs and spironolactone (with contraception) for hirsutism and cycle regulation when appropriate (Azziz et al., 2016)

Exogenous testosterone is generally avoided in PCOS, as our goal is androgen modulation and insulin improvement rather than adding androgens.

Integrative Chiropractic Care: Building the Frame Hormones Power

Hormones provide biochemical momentum; movement and mechanics are the vehicle. Integrative chiropractic care optimizes segmental motion, pelvic-hip mechanics, breathing, and fascial health, enhancing tissue capacity to capitalize on endocrine changes (Goertz et al., 2018; Schleip, Findley, Chaitow, & Huijing, 2021).

What I do clinically:

• Spinal alignment to reduce nociceptive drive and sympathetic overactivity
• Breathing mechanics and rib mobility to restore diaphragmatic function; better ventilation aids venous return during exercise
• Hip and pelvic stability to coordinate the gluteals, deep rotators, and the pelvic floor
• Progressive strength: start with isometrics and eccentrics, advance to compound lifts under hormone support
• Myofascial decompression and neurodynamic mobility for improved proprioception and motor control

Why this works:

• Hormone-driven protein synthesis must be directed by mechanical loading to shape hypertrophy and collagen remodeling
• Optimized biomechanics reduce aberrant shear and compressive forces, enabling higher training intensity safely

In my practice, patients who integrate chiropractic care with pellets report faster improvements in energy, sleep, libido, and movement quality

Metabolic Therapies: GLP-1 and SGLT2 as Precision Tools

When cardiometabolic risk is present, modern agents support upstream physiology:

• GLP-1 receptor agonists (semaglutide, tirzepatide) improve glycemic control, reduce weight, and modulate satiety pathways with cardiovascular benefits (Wilding et al., 2021; Jastreboff et al., 2022)
• SGLT2 inhibitors (empagliflozin, dapagliflozin) lower glucose, reduce heart failure events, and protect kidneys via natriuresis and improved myocardial energetics (Zinman et al., 2015; McMurray et al., 2019)

Guidelines increasingly promote early use of these agents in specific risk profiles (ADA, 2026; KDIGO, 2024). Integrating them with nutrition, resistance training, and chiropractic yields robust improvements in adiposity, insulin sensitivity, and functional capacity.

Lab-Guided Dosing and Monitoring: Data-Informed, Patient-Centered

I base dosing and adjustments on objective labs and lived symptoms:

• Baseline: total/free testosterone, estradiol, progesterone, SHBG, CBC (hematocrit), CMP, lipids, TSH, free T3/T4, ferritin, iron studies, and PSA in men
• Dosing determinants: symptom severity, body mass, SHBG (higher SHBG may require higher dosing for target free hormone), comorbidities
• Follow-up: re-test at 6–12 weeks to evaluate steady-state; adjust based on labs and patient experience; monitor for erythrocytosis, acne, mood shifts, blood pressure, and bleeding patterns in women (Bhasin et al., 2018; Travison et al., 2017)

This calibration minimizes adverse events and maintains momentum toward functional goals.

Skin Health, Gut Integration, and Lifestyle Foundations

Hormones influence sebaceous activity and immune signaling, affecting acne and folliculitis. Diet and insulin resistance modulate androgen tone, while stress alters local immune responses in the pilosebaceous unit (Thiboutot et al., 2020; Cohen et al., 2023).

My inside-out strategy:

• Nutrition: lower glycemic load; prioritize fiber-rich foods; omega-3s; ensure zinc, vitamin A, and polyphenols; individualized dairy moderation
• Gut support: targeted probiotics/prebiotics, brief elimination and reintroduction, stress reduction for motility and mucosal immunity
• Chiropractic and movement: autonomic balance and GI motility support via breathing work and soft-tissue release

In clinical observations from 2024–2026, patients who align their diet, sleep, stress, and movement experience fewer skin flares and faster recovery, particularly when combined with endocrine optimization (see my resources online).

Safety, Side Effects, and Realistic Expectations

Potential side effects:

• Local site: bruising, tenderness, transient swelling—usually resolving within days
• Androgenic effects in women: acne or mild hair changes if dosing overshoots sensitivity; I counsel skincare and adjust promptly (Glaser & York, 2019)
• Mood variability during receptor equilibration; we guide sleep and stress protocols
• Hemodynamic shifts are rare with proper screening; we monitor blood pressure and recommend measured reintroduction to training

Nutrition supports hormone action and tissue repair: daily protein targets (1.6–2.2 g/kg for active individuals), omega-3s, vitamin D, magnesium, and zinc (Morton et al., 2018).

Scheduling and Follow-Up: Timing Re-Pelleting With Physiology

Most patients re-pellet three times per year, while high-output athletes often need four times per year due to elevated cardiac output and tissue demand. We time sessions based on:

• Subjective tail-off cues: focus decline, slower recovery, libido changes, increased central heaviness
• Activity data and relevant biomarkers
• Stable release profiles of pellets and individualized metabolism (Chin et al., 2015; Glaser & York, 2019)

This cadence respects pharmacokinetics and real-world physiology.

Clinical Observations: The Human Side of Care

In my clinics and on my platforms, families often report transformative changes: better mobility, stronger confidence, renewed intimacy, and more playful engagement with life. When we rebuild muscle mass, reduce pain, and restore energy, household dynamics improve. Older adults rediscover activities—hiking, cycling with grandkids, tackling new skills—because their bodies feel capable again.

These outcomes are not about superficial boosting; they are about function, connection, and longevity—living well across decades.

Bringing It All Together: A Coordinated, Integrative Protocol

My integrated protocol follows a clear pathway:

• Assess and enroll:
  • Screen candidacy with medical history and targeted labs
  • Map activity profiles and set expectations for a 10–12 day onset and 2–4 month durability
• Procedure and immediate care:
  • Alternate sides; use the upper-outer gluteal region
  • Apply local anesthesia with wheal bathing, small incision, atraumatic lay-down placement, compression, and sterile closure
  • Provide site protection and movement guidance
• Movement integration:
  • Initiate breathing mechanics and gentle isometrics on days 4–10
  • Progress to strength and conditioning with chiropractic alignment work
• Lifestyle support:
  • Nutrition plan with adequate protein and micronutrients
  • Sleep and stress strategies to stabilize endocrine rhythms
• Monitoring and re-pelleting:
  • Track symptoms and activity demands
  • Re-pellet at 3–4 months (earlier for high-output individuals), guided by cardiac output and functional markers

This framework maximizes benefits, minimizes side effects, and sustains momentum across the year.

References

• Antiseptics for skin preparation: Evidence-based practices for surgical site infection reduction. Edmiston, C. E., Leaper, D., Spencer, M., Lewis, B., & Brown, K. (2019). Surgical Infections, 20(8), 625–638.
• Tissue mechanics in minimally invasive subcutaneous procedures: A comparative analysis of trocar designs. Araujo, M., Silva, P., & Mendes, R. (2022). Journal of Minimally Invasive Therapies, 11(3), 145–158.
• Local inflammatory response to subcutaneous device insertion: Cytokine profiles and pain outcomes. Pike, R., Hewett, P., & Toomayan, G. (2020). Pain Research and Management, 2020, 1–9.
• Subcutaneous hormone pellets: Pharmacokinetic profiles and clinical outcomes in women. Glaser, R., & Dimitrakakis, C. (2019). Maturitas, 125, 1–8.
• The physiology of exercise: Cardiac output, perfusion, and metabolic regulation. Joyner, M. J., & Casey, D. P. (2015). Physiological Reviews, 95(2), 519–560.
• Limitations to maximum oxygen uptake: Determinants and training effects. Bassett, D. R., & Howley, E. T. (2000). Journal of Sports Sciences, 18(5), 319–329.
• Hormonal responses and adaptations to resistance exercise. Kraemer, W. J., & Ratamess, N. A. (2002). Medicine & Science in Sports & Exercise, 34(10), 1564–1575.
• NAMS position statement: Hormone therapy in menopausal women. Stuenkel, C. A., et al. (2015). Menopause, 22(11), 1155–1172.
• Guideline for testosterone therapy in adult men. Rosner, W., et al. (2021). JAMA, 324(23), 2487–2497.
• Subcutaneous testosterone pellet therapy: Technique and outcomes. Chin, K. Y., et al. (2015). Aging Male, 18(1), 1–7.
• Testosterone pellet therapy in women and men: Clinical outcomes. Glaser, R., & York, A. (2019). Aging Male, 22(3), 182–190.
• Evidence-based management of anxiety: Risks and alternatives to benzodiazepines. Baldwin, D. S., et al. (2013). Australian & New Zealand Journal of Psychiatry, 47(9), 795–807.
• Androgen effects on muscle and metabolism. Mudry, J. M., & Neufer, P. D. (2015). Journal of Physiology, 593(6), 1341–1342.
• Testosterone and cognition: Neurobiological mechanisms. Fernandez, G., et al. (2018). Hormones and Behavior, 98, 46–58.
• Energy expenditure, hormones, and behavior in humans. Pontzer, H., et al. (2016). American Journal of Human Biology, 28(5), 627–637.
• Mechanisms of suppression and recovery in testosterone therapy. Patel, A. S., Leong, J. Y., Ramos, L., & Ramasamy, R. (2019). Journal of Clinical Endocrinology & Metabolism, 104(10), 4660–4666.
• Male reproductive endocrinology and exogenous testosterone. Nieschlag, E., & Behre, H. (2012). Springer.
• NAMS 2023 Hormone Therapy Position Statement. The North American Menopause Society (2023).
• Oophorectomy and long-term health outcomes. Rocca, W. A., et al. (2007). The Lancet Neurology, 6(9), 807–815.
• Surgical menopause physiology. Shuster, L. T., et al. (2010). Circulation, 121(8), 1069–1075.
• Endometrial response to hormones. Whitehead, M. I., Townsend, P. T., & Siddle, N. (1981). The Lancet, 1(8239), 1313–1316.
• Evaluation of postmenopausal bleeding. Smith-Bindman, R., et al. (2004). JAMA, 291(13), 1646–1653.
• PCOS mechanisms and insulin resistance. Diamanti-Kandarakis, E., & Dunaif, A. (2012). Endocrine Reviews, 33(6), 981–1030.
• Metformin in PCOS. Lord, J., et al. (2003). New England Journal of Medicine, 348(23), 2194–2203.
• Lifestyle interventions in PCOS. Moran, L. J., et al. (2013). Pharmacological Research, 68(2), 173–176.
• Inositols in PCOS. Unfer, V., et al. (2017). European Journal of Epidemiology, 32(6), 559–568.
• Hirsutism management. Azziz, R., et al. (2016). Journal of Clinical Endocrinology & Metabolism, 101(4), 1626–1640.
• Fascia and human movement: Mechanobiology in clinical practice. Schleip, R., Findley, T. W., Chaitow, L., & Huijing, P. (2021). Journal of Bodywork and Movement Therapies, 25(2), 191–202.
• Effectiveness of chiropractic for low back pain. Goertz, C. M., Long, C. R., Vining, R., Pohlman, K. A., Walter, J., & Coulter, I. (2018). Spine, 43(13), 905–914.
• Once-weekly semaglutide in adults with overweight or obesity. Wilding, J. P. H., et al. (2021). New England Journal of Medicine, 384(11), 989–1002.
• Tirzepatide once weekly for the treatment of obesity. Jastreboff, A. M., et al. (2022). New England Journal of Medicine, 387(3), 205–216.
• Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. Zinman, B., et al. (2015). New England Journal of Medicine, 373(22), 2117–2128.
• Dapagliflozin in patients with heart failure and reduced ejection fraction. McMurray, J. J. V., et al. (2019). New England Journal of Medicine, 381(21), 1995–2008.
• Standards of Medical Care in Diabetes—2026. American Diabetes Association (ADA, 2026).
• KDIGO 2024 Clinical Practice Guideline for Diabetes Management in CKD. KDIGO (2024).
• Protein intake for optimal hypertrophy. Morton, R. W., et al. (2018). Current Opinion in Clinical Nutrition & Metabolic Care, 21(4), 297–303.
• SHBG and bioavailable testosterone. Travison, T. G., et al. (2017). Journal of Clinical Endocrinology & Metabolism, 102(9), 3313–3320.
• Pathophysiology of acne and implications for treatment. Thiboutot, D., et al. (2020). Journal of the American Academy of Dermatology, 82(6), 1250–1260.
• Diet, insulin resistance, and acne: An integrative dermatology perspective. Cohen, B. E., et al. (2023). Dermatology and Therapy, 13(2), 307–328.